Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trialVanderbeke, Lore ; Janssen, Nico A. F. ; Bergmans, Dennis C. J. J. ; Bourgeois, Marc ; Buil, Jochem B. ; Debaveye, Yves ; Depuydt, Pieter ; Feys, Simon ; Hermans, Greet ; Hoiting, Oscar ; van der Hoven, Ben ; Jacobs, Cato ; Lagrou, Katrien ; Lemiale, Virginie ; Lormans, Piet ; Maertens, Johan ; Meersseman, Philippe ; Mégarbane, Bruno ; Nseir, Saad ; van Oers, Jos A. H. ; Reynders, Marijke ; Rijnders, Bart J. A. ; Schouten, Jeroen A. ; Spriet, Isabel ; Thevissen, Karin ; Thille, Arnaud W. ; Van Daele, Ruth ; van de Veerdonk, Frank L. ; Verweij, Paul E. ; Wilmer, Alexander ; Brüggemann, Roger J. M. ; Wauters, JoostIntensive care medicine, 2021-06, Vol.47 (6), p.674-686 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
|
2 |
Material Type: Artigo
|
C-Terminal Proarginine Vasopressin is Associated with Disease Outcome and Mortality, but not with Delayed Cerebral Ischemia in Critically Ill Patients with an Aneurysmal Subarachnoid Hemorrhage: A Prospective Cohort Studyvan Oers, Jos A. H. ; Ramnarain, Dharmanand ; Oldenbeuving, Annemarie ; Vos, Piet ; Roks, Gerwin ; Kluiters, Yvette ; Beishuizen, Albertus ; de Lange, Dylan W. ; de Grooth, Harm-Jan ; Girbes, Armand R. J.Neurocritical care, 2022-12, Vol.37 (3), p.678-688 [Periódico revisado por pares]New York: Springer USTexto completo disponível |
|
3 |
Material Type: Artigo
|
Endothelium-associated biomarkers mid-regional proadrenomedullin and C-terminal proendothelin-1 have good ability to predict 28-day mortality in critically ill patients with SARS-CoV-2 pneumonia: A prospective cohort studyvan Oers, Jos A.H. ; Kluiters, Yvette ; Bons, Judith A.P. ; de Jongh, Mariska ; Pouwels, Sjaak ; Ramnarain, Dharmanand ; de Lange, Dylan W. ; de Grooth, Harm-Jan ; Girbes, Armand R.J.Journal of critical care, 2021-12, Vol.66, p.173-180 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
|
4 |
Material Type: Artigo
|
Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trialde Jong, Evelien, Dr ; van Oers, Jos A, MD ; Beishuizen, Albertus, MD ; Vos, Piet, RN ; Vermeijden, Wytze J, MD ; Haas, Lenneke E, MD ; Loef, Bert G, MD ; Dormans, Tom, MD ; van Melsen, Gertrude C, MD ; Kluiters, Yvette C, PhD ; Kemperman, Hans, PhD ; van den Elsen, Maarten J, MD ; Schouten, Jeroen A, MD ; Streefkerk, Jörn O, MD ; Krabbe, Hans G, PhD ; Kieft, Hans, MD ; Kluge, Georg H, MD ; van Dam, Veerle C, MD ; van Pelt, Joost, MD ; Bormans, Laura, RN ; Otten, Martine Bokelman, MD ; Reidinga, Auke C, MD ; Endeman, Henrik, MD ; Twisk, Jos W, Prof ; van de Garde, Ewoudt M W, PhD ; de Smet, Anne Marie G A, Prof ; Kesecioglu, Jozef, Prof ; Girbes, Armand R, Prof ; Nijsten, Maarten W, MD ; de Lange, Dylan W, MDThe Lancet infectious diseases, 2016-07, Vol.16 (7), p.819-827 [Periódico revisado por pares]United States: Elsevier LtdTexto completo disponível |
|
5 |
Material Type: Artigo
|
Response to: MR-proADM has a good ability to predict mortality in critically ill patients with SARS-CoV-2 pneumonia: Beware of some potential confoundersvan Oers, Jos A.H. ; de Grooth, Harm-Jan ; de Lange, Dylan W. ; Girbes, Armand R.J.Journal of critical care, 2022-02, Vol.67, p.214-215 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
|
6 |
Material Type: Artigo
|
Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patientsAssink-de Jong, Evelien ; de Lange, Dylan W ; van Oers, Jos A ; Nijsten, Maarten W ; Twisk, Jos W ; Beishuizen, AlbertusBMC infectious diseases, 2013-04, Vol.13 (1), p.178-178, Article 178 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |
|
7 |
Material Type: Artigo
|
Is a Single Initial Procalcitonin Test Sufficient in Septic, Critically Ill Patients to Minimize Antibiotic Use?van Oers, Jos A.H. ; de Jong, Evelien ; Beishuizen, Albertus B. ; Nijsten, Maarten W. ; Girbes, Armand R. ; de Lange, Dylan W.Chest, 2017-07, Vol.152 (1), p.218-219 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
|
8 |
Material Type: Archival Material / Manuscript
|
Why would procalcitonin perform better in patients with a SOFA-score less than 8?van Oers, Jos A H ; Nijsten, Maarten W ; de Jong, Evelien ; Beishuizen, Albertus ; de Lange, Dylan W2019Texto completo disponível |